The activation of PI3K/Akt/mTOR signaling also plays an important role in HNSCC chemotherapy and radiotherapy resistances, as the inhibition of the signaling pathway has shown positive effects on tumor proliferation and radiotherapy sensitization in preclinical studies [37,38]. This evidence concerns the gene MTOR and head and neck squamous cell carcinoma.